| 000 | nab a22 7a 4500 | ||
|---|---|---|---|
| 999 |
_c16645 _d16645 |
||
| 003 | PC16645 | ||
| 005 | 20211105095355.0 | ||
| 008 | 211105b xxu||||| |||| 00| 0 eng d | ||
| 040 | _cH12O | ||
| 041 | _aeng | ||
| 100 |
_9389 _aMartínez López, Joaquín _eHematología y Hemoterapia |
||
| 245 | 0 | 4 |
_aThe International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis. _h[carta] |
| 260 |
_bHaematologica, _c2014 |
||
| 300 | _a99(4):e55-7. | ||
| 500 | _aFormato Vancouver: Hernández Boluda JC, Pereira A, Gómez M, Boqué C, Ferrer Marín F, Raya JM et al; Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas. The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis. Haematologica. 2014 Apr;99(4):e55-7. | ||
| 501 | _aPMID: 24488561 PMC3971095 | ||
| 504 | _aContiene 13 referencias | ||
| 520 | _a No abstract available | ||
| 710 |
_9297 _aServicio de Hematología y Hemoterapia |
||
| 856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc16645.pdf _ySolicitar documento |
||
| 942 |
_2ddc _cCRT _n0 |
||